Bausch Health Companies Stock Current Valuation
| BHC Stock | CAD 10.68 0.37 3.35% |
Valuation analysis of Bausch Health Companies helps investors to measure Bausch Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 6th of May 2024, Enterprise Value Over EBITDA is likely to drop to 8.01. In addition to that, Enterprise Value Multiple is likely to drop to 8.01. Fundamental drivers impacting Bausch Health's valuation include:
Price Book 18.7424 | Enterprise Value 26.2 B | Enterprise Value Ebitda 15.3381 | Price Sales 0.5054 | Forward PE 2.4266 |
Fairly Valued
Today
Please note that Bausch Health's price fluctuation is not too volatile at this time. Calculation of the real value of Bausch Health Companies is based on 3 months time horizon. Increasing Bausch Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Bausch Health Companies is useful when determining the fair value of the Bausch stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Bausch Health. Since Bausch Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bausch Stock. However, Bausch Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.68 | Real 10.32 | Hype 10.68 |
The real value of Bausch Stock, also known as its intrinsic value, is the underlying worth of Bausch Health Companies Company, which is reflected in its stock price. It is based on Bausch Health's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Bausch Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bausch Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bausch Health Companies helps investors to forecast how Bausch stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bausch Health more accurately as focusing exclusively on Bausch Health's fundamentals will not take into account other important factors: Bausch Health Companies Company Current Valuation Analysis
Bausch Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bausch Health Current Valuation | 26.2 B |
Most of Bausch Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bausch Health Companies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bausch Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Bausch Health is extremely important. It helps to project a fair market value of Bausch Stock properly, considering its historical fundamentals such as Current Valuation. Since Bausch Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bausch Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bausch Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bausch Health Companies has a Current Valuation of 26.2 B. This is 82.4% higher than that of the Pharmaceuticals sector and 252.39% higher than that of the Health Care industry. The current valuation for all Canada stocks is 57.6% lower than that of the firm.
Bausch Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bausch Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics of similar companies.Bausch Health is currently under evaluation in current valuation category among related companies.
Bausch Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bausch Health from analyzing Bausch Health's financial statements. These drivers represent accounts that assess Bausch Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bausch Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 10.5B | 7.3B | 9.8B | 2.9B | 2.6B | 2.5B | |
| Enterprise Value | 33.2B | 30.7B | 31.9B | 24.4B | 21.9B | 14.2B |
Bausch Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bausch Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bausch Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Bausch Fundamentals
| Return On Equity | -6.87 | ||||
| Return On Asset | 0.0404 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 26.2 B | ||||
| Shares Outstanding | 366.8 M | ||||
| Shares Owned By Insiders | 0.91 % | ||||
| Shares Owned By Institutions | 78.97 % | ||||
| Number Of Shares Shorted | 1.83 M | ||||
| Price To Book | 18.74 X | ||||
| Price To Sales | 0.51 X | ||||
| Revenue | 8.76 B | ||||
| Gross Profit | 5.76 B | ||||
| EBITDA | 2.96 B | ||||
| Net Income | (592 M) | ||||
| Cash And Equivalents | 564 M | ||||
| Cash Per Share | 2.49 X | ||||
| Total Debt | 450 M | ||||
| Debt To Equity | 906.20 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | (3.04) X | ||||
| Cash Flow From Operations | 1.12 B | ||||
| Short Ratio | 3.75 X | ||||
| Earnings Per Share | (1.69) X | ||||
| Price To Earnings To Growth | 0.02 X | ||||
| Target Price | 14.01 | ||||
| Number Of Employees | 20.27 K | ||||
| Beta | 0.86 | ||||
| Market Capitalization | 3.92 B | ||||
| Total Asset | 27.35 B | ||||
| Retained Earnings | (9.78 B) | ||||
| Working Capital | 1.29 B | ||||
| Net Asset | 27.35 B |
About Bausch Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bausch Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bausch Health's short interest history, or implied volatility extrapolated from Bausch Health options trading.
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
| 0.82 | BRK | Berkshire Hathaway CDR | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |